These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6330851)

  • 41. Polio eradication. Rethinking the polio endgame.
    Roberts L
    Science; 2009 Feb; 323(5915):705. PubMed ID: 19197036
    [No Abstract]   [Full Text] [Related]  

  • 42. Inactivated Polio Vaccine (IPV): a strong candidate vaccine for achieving global polio eradication program.
    Shahzad A; Köhler G
    Vaccine; 2009 Aug; 27(39):5293-4. PubMed ID: 19638271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stopping a polio outbreak in the post-eradication era.
    Fine PE; Sutter RW; Orenstein WA
    Dev Biol (Basel); 2001; 105():129-47; discussion 149-50. PubMed ID: 11763322
    [No Abstract]   [Full Text] [Related]  

  • 44. OPV cannot eradicate polio from India: do we need any further evidence?
    Paul Y
    Vaccine; 2008 Apr; 26(17):2058-61. PubMed ID: 18378367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gaps in scientific knowledge for the post eradication world.
    Minor P
    Biologicals; 2006 Jun; 34(2):167-70. PubMed ID: 16678439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficiency and reliability of polio surveillance.
    Hovi T
    Dev Biol (Basel); 2001; 105():21-31. PubMed ID: 11763329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral polio vaccines and their role in polio eradication in India.
    Paul Y
    Expert Rev Vaccines; 2009 Jan; 8(1):35-41. PubMed ID: 19093771
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child.
    Hidalgo S; García Erro M; Cisterna D; Freire MC
    Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification?
    Dowdle WR; Wolff C; Sanders R; Lambert S; Best M
    Bull World Health Organ; 2004 Jan; 82(1):59-62. PubMed ID: 15106302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
    Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intratypic differentiation of poliovirus strains of type I from pre- and post-vaccination groups.
    Sevani HK; Gharpure PV
    Indian J Med Res; 1969 Sep; 57(9):1591-606. PubMed ID: 4313048
    [No Abstract]   [Full Text] [Related]  

  • 53. [Test of the potency of trivalent oral polio vaccines: comparison of 2 methods of reading].
    Chocarro LB; Manau MV
    Rev Argent Microbiol; 1987; 19(2):65-9. PubMed ID: 2459727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polio endgame. Polio: The final assault?
    Roberts L
    Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
    [No Abstract]   [Full Text] [Related]  

  • 55. [Properties of poliovirus detected in waste waters in the administration of nonhomogeneous vaccine (author's transl)].
    Matyásová I; Koza J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Jan; 30(1):49-55. PubMed ID: 6258812
    [No Abstract]   [Full Text] [Related]  

  • 56. [Considerations on the etiology of facial paralysis. I].
    Ionescu N; Ciupe M; Sovrea D; Dimoftache E; Fogarassy F; Donogany A; Iuraşog G
    Stud Cercet Inframicrobiol; 1968; 19(4):273-80. PubMed ID: 4304407
    [No Abstract]   [Full Text] [Related]  

  • 57. Postoutbreak polio vaccination policy in Israel.
    Slater PE
    Am J Dis Child; 1990 Aug; 144(8):850-1. PubMed ID: 2378326
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 59. Change in polio strategy?
    Roberts L
    Science; 1988 May; 240(4856):1145. PubMed ID: 3375808
    [No Abstract]   [Full Text] [Related]  

  • 60. Potency testing of killed polio vaccine in rats.
    van Steenis G; van Wezel AL; Sekhuis VM
    Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.